UBS Group AG - BLACKROCK HEALTH SCIENCES TR ownership

BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 56 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BLACKROCK HEALTH SCIENCES TR
ValueSharesWeighting
Q3 2023$4,502,094
+30.0%
114,996
+35.0%
0.00%
+100.0%
Q2 2023$3,462,650
-0.8%
85,203
+2.2%
0.00%0.0%
Q1 2023$3,490,078
+23.0%
83,375
+28.0%
0.00%0.0%
Q4 2022$2,838,234
-55.2%
65,127
-60.1%
0.00%
-66.7%
Q3 2022$6,337,000
-6.5%
163,241
+2.1%
0.00%0.0%
Q2 2022$6,778,000
+16.6%
159,864
+25.2%
0.00%
+50.0%
Q1 2022$5,813,000
+9.5%
127,702
+16.7%
0.00%0.0%
Q4 2021$5,307,000
+2.9%
109,414
+1.1%
0.00%0.0%
Q3 2021$5,158,000
+0.3%
108,253
+2.1%
0.00%0.0%
Q2 2021$5,141,000
+7.3%
105,986
+2.3%
0.00%0.0%
Q1 2021$4,791,000
-2.7%
103,582
+0.1%
0.00%0.0%
Q4 2020$4,923,000
+12.3%
103,447
+1.1%
0.00%0.0%
Q3 2020$4,385,000
+17.0%
102,318
+11.3%
0.00%0.0%
Q2 2020$3,748,000
+31.5%
91,903
+16.2%
0.00%
+100.0%
Q1 2020$2,850,000
+32.4%
79,070
+56.1%
0.00%0.0%
Q4 2019$2,153,000
+12.4%
50,651
+1.1%
0.00%0.0%
Q3 2019$1,916,000
+8.1%
50,091
+9.9%
0.00%0.0%
Q2 2019$1,773,000
-17.0%
45,598
-15.1%
0.00%0.0%
Q1 2019$2,136,000
+13.4%
53,685
+3.9%
0.00%0.0%
Q4 2018$1,884,000
+5.3%
51,681
+22.9%
0.00%0.0%
Q3 2018$1,789,000
+13.4%
42,065
+2.9%
0.00%0.0%
Q2 2018$1,577,000
+7.9%
40,873
-2.2%
0.00%0.0%
Q1 2018$1,462,000
-15.2%
41,777
-11.6%
0.00%0.0%
Q4 2017$1,725,000
+26.7%
47,239
+26.4%
0.00%0.0%
Q3 2017$1,362,000
+1.3%
37,363
+1.9%
0.00%0.0%
Q2 2017$1,344,000
+12.9%
36,667
+6.6%
0.00%0.0%
Q1 2017$1,190,000
+30.2%
34,409
+19.5%
0.00%0.0%
Q4 2016$914,000
+6.0%
28,785
+14.7%
0.00%0.0%
Q3 2016$862,000
+14.3%
25,086
+18.6%
0.00%
Q2 2016$754,000
+14.6%
21,156
+14.0%
0.00%
Q1 2016$658,000
-10.8%
18,552
-1.0%
0.00%
Q4 2015$738,000
-3.4%
18,742
-7.9%
0.00%
-100.0%
Q3 2015$764,000
-0.1%
20,346
+13.8%
0.00%0.0%
Q2 2015$765,000
-8.3%
17,884
-7.8%
0.00%0.0%
Q1 2015$834,000
+5.2%
19,394
+4.4%
0.00%0.0%
Q4 2014$793,00018,5750.00%
Other shareholders
BLACKROCK HEALTH SCIENCES TR shareholders Q3 2021
NameSharesValueWeighting ↓
Ahrens Investment Partners LLC 74,825$3,561,0001.91%
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC 40,961$1,174,0000.99%
Diversified, LLC 19,077$818,0000.70%
CORRADO ADVISORS, LLC 9,645$459,0000.35%
Rikoon Group, LLC 16,672$793,0000.22%
Eudaimonia Partners, LLC 8,240$392,0000.09%
Arete Wealth Advisors, LLC 10,658$507,0000.07%
SOA Wealth Advisors, LLC. 4,900$242,0000.07%
Financial Advantage, Inc. 833$39,0000.04%
Jacobi Capital Management LLC 4,184$199,0000.03%
View complete list of BLACKROCK HEALTH SCIENCES TR shareholders